Thierry has more than 5 years of Global Pharmacovigilance Auditing experience and is now a member of the BARQA Good Pharmacovigilance Practice Committee.
Highlights include major
corporate audits and MHRA and FDA Pharmacovigilance Inspections, widely recognized as leading Regulatory Authorities in this field.
The following table details the most significant projects:
| 2006 |
Audit of Pharmacovigilance Operations at the Spanish subsidiary of Bayer HealthCare |
Led the preparation, conduct, and reporting of the audit. This audit was performed wit the assistance of 2 Bayer HealthCare auditors. |
Spain |
| 2006 |
Review of Clinical Safety and Pharmacovigilance Processes at the UK affiliate of Kyowa Hakko, including aspects related to EU/RoW coordinating role
|
Led the preparation, conduct, and reporting of the audit. |
UK |
| 2006 |
Review of Clinical Safety and Pharmacovigilance Processes within Grünenthal Corporate Headquarters and two selected affiliates |
Led the preparation, conduct, and reporting of the audit. This audit was performed together with an auditor from Grünenthal Corporate Quality Assurance. |
Germany and other European countries |
| 2006 |
Audit of Clinical Safety Service Provider for Biopartners
|
Led the preparation, conduct, and reporting of the audit. |
Germany |
| 2006 |
Review of the Medical Information Processes at provider contracted by Bayer Consumer Care Division |
Led the preparation, conduct, and reporting of the audit. |
UK |
| 2006 |
Review of EU Drug Safety Processes at the European Drug Safety Unit at GPC Biotech
|
Led the preparation, conduct, and reporting of the audit. |
Germany |
| 2006 |
Audit of Clinical Safety Service Provider for BioVex |
Led the preparation, conduct, and reporting of the audit. |
UK |
| 2005 |
Mock Inspection of
Global Drug Safety (GDS), Bayer HealthCare AG
|
Led the preparation, conduct, and reporting of the audit. T. Hamard was the sole member of the audit team |
Germany |
| 2005 |
Audit of Pharmacovigilance Operations at the French subsidiary of Bayer HealthCare AG |
Led the preparation, conduct, and reporting of the audit. |
France |
| 2005 |
Follow-up of EMEA Pharmacovigilance Inspection at the UK Drug Safety Unit of Schering-Plough |
Consulting on the actions to complete in order to promote success of future inspections |
UK |
| 2005 |
Review of the Medical Information Processes at the Call Center contracted by Bayer Consumer Care Division |
Led the preparation, conduct, and reporting of the audit. T. Hamard was the sole member of the audit team |
UK |
| 2004 |
Audit of Global Pharmacovigilance Unit of Altana Pharma |
Led the preparation, conduct, and reporting of the audit. T. Hamard was the sole member of the audit team. The audit covered the activities of the Global Pharmacovigilance Unit of Altana Pharma, which also assumed the responsibility of Local Drug Safety Unit for Germany |
Germany |
| 2004 |
Audit of Pharmacovigilance processes at the OTC Products Division of Bayer |
Led the preparation, conduct, reporting and follow-up of the audit |
Germany, Spain and USA |
| 2004 |
Audit of Pharmacovigilance processes at the Biological Products Division of Bayer |
Led the preparation, conduct, reporting and follow-up of the audit |
USA |
| 2004 |
Audit of Pharmacovigilance processes at a partner company |
Led the preparation, conduct, reporting and follow-up of the audit |
UK |
| 2003 |
Preparation, conduct & follow-up of local Pharmacovigilance Inspection |
Led the preparation, attended the conduct and contributed to the follow-up for a MHRA Pharmacovigilance Inspection |
UK |
| 2002-2003 |
System audit of Global Pharmacovigilance Processes for Bayer |
Led the preparation, conduct, reporting and follow-up of the audit |
UK, USA, Germany, Italy, Spain, Mexico, Japan and China |
| 2002 |
Follow-up of local Pharmacovigilance Inspection |
Contributed to the identification of corrective actions |
Portugal |
| 2001 |
Preparation for local Pharmacovigilance Inspection |
Supervised the preparation, conduct and reporting of a pre-inspection audit by a corporate auditor |
USA |
| 2001 |
Preparation for local Pharmacovigilance Inspection |
Led the preparation and supervised the conduct and reporting of a pre-inspection audit by a contract auditor |
France |
| 2001 |
Preparation & follow-up of FDA Inspection at the corporate Pharmacovigilance department |
Led the preparation, conduct and reporting of a pre-inspection audit |
Germany |
| 2000 |
Follow-up of local Pharmacovigilance Inspection |
Involvement for corrective actions after inspection |
The Netherlands |